The impact of PET with 18FDG in radiotherapy treatment planning and in the prediction in patients with cervix carcinoma - Results of pilot study

Neoplasma

Volumn 55, Issue 5, 2008, Pages 437-441

  Dolezelova, H ^a   Slampa, P ^a   Ondrova, B ^a   Gombosova, J ^a   Sovadinova, S ^a   Novotny, T ^a   Bolcak, K ^b   Ruzickova, J ^a   Hynkova, L ^a   Forbelska, M ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

18 F fluorodeoxyglucose; Cervical carcinoma; Positron emission tomography; Radiotherapy

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRACHYTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE; MAJOR CLINICAL STUDY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIATION INJURY; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA; COMPARATIVE STUDY; EVALUATION; MIDDLE AGED; PATIENT CARE PLANNING; SCINTISCANNING; UTERINE CERVIX TUMOR;

ADULT; AGED; BRACHYTHERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PATIENT CARE PLANNING; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 53449083473     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. STANKUŠOVÁ H, ŠLAMPA P. Cervical carcinoma. In: ŠLAMPA P, PETERA J. Radiation oncology. Praha, Galen; 2007: 247-262.
2. NCI. Cervical, endometrial, Ovarian Cancer: Prevention: Incidention and Mortality. www.nci.nih.gov
3. KAUŠITZ J, ALTANER Č. Onkológia. Bratislava, Veda; 2003: 435-441.
4. rd ed., Philadelphia, Lippincott&Wilkins; 2004: 791-896.
5. BUJENOVIC S. The role of positron emission tomography in radiation treatment planning. Sem Nucl Med 2004; 34: 293-299. (Pubitemid 39361038)
6. GROSU AL, PIERT M, WEBER WA,et al. Positron emission tomography for radiation treatment planning. Strahlenther Oncol 2005; 8: 483-499.
7. COHADE C, WAHL R. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvement. Sem Nucl Med 2003; 33: 228-237.
8. DOLEŽELOVÁ H, ŠLAMPA P. The impact of positron emission tomography in the radiotherapy treatment planning. Neoplasma 2007; 54 : 95-100.
9. RIGO P, HUSTINX R, BURY T. PET imaging in lung cancer. In: Valk PE, Bailey DL, Townsend DW, Maisey MN, editors. Positron Emission and Tomography: Basic Science and Clinical Practice. London, UK: Springer; 2003. 517-534.
10. PAULINO AC, KOSHY M, HOWELL R. Comparison of CT and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 1385-1392.
11. RYU SY, KIM MH, CHOI SC, et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 2003; 44: 347-352 (Pubitemid 39586009)
12. BELHOCINE T, THILLE A, FRIDMAN V, et al. Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 2002; 87(1): 90-97. (Pubitemid 36027107)
13. GAMBHIR SS, CZERNIN J, SCHWIMMER J, et al. A tabulated summary of the FDG-PET literature. J Nucl Med 2001; 42: S1-93.
14. GRIGSBY PW, SIEGEL BA, DEHDASHTI F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001; 19: 3745-3749. (Pubitemid 32844787)
15. GRIGSBY PW, SIEGEL BA, DEHDASHTI F. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 2003; 55: 907-913.
16. SINGH AK, GRIGSBY PW, DEHDASHTI F, et al. PDG-PET lymf node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys 2003; 56(2): 489-493.
17. ROSE PG, ADLER LP, RODRIGUEZ M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging:A surgicopathologic study. J Clin Oncol 1999; 17(1): 41-45.
18. NAKAMOTO Y, EISBRUCH A, ACHTYES ED. Prognostic value of positron tomography using F-18-Fluorodeoxyglucose in patients with cervical cancer undergoing radiotherapy. Gynecol Oncol 2002; 84: 289-295.
19. KITAGAWA Y, SADATO N, AZUMA H, et al. FDG PET to evaluace combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasm. J Nucl Med 1999; 40(2): 1132-1137.
20. ICHIYA Y, KUWABARA Y, OTSUKA M, et al. Assesment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991; 32: 1655-1660.
21. KOIKE I, OHMURA M, HATA M, et al. FDG-PET scanning after radiation can predict tumor regrowth three months later. Int J Radiat Oncol Biol Phys 2003; 57(5): 1231-1238.